enGene Therapeutics Inc. - Common Shares (ENGN)

CUSIP: 29286M105

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Shares
Shares outstanding
67,348,192
Total 13F shares
14,187,864
Share change
+5,509,913
Total reported value
$130,941,207
Price per share
$9.23
Number of holders
11
Value change
+$50,843,719
Number of buys
10

Quarterly Holders Quick Answers

What is CUSIP 29286M105?
CUSIP 29286M105 identifies ENGN - enGene Therapeutics Inc. - Common Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ENGN - enGene Therapeutics Inc. - Common Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Forbion Growth Sponsor FEAC I B.V.
3/4/5
10%+ Owner —
mixed-class rows
5,502,338
mixed-class rows
 — — 31 Oct 2023
3/4/5
Forbion Capital Fund III Cooperatief U.A.
3/4/5
10%+ Owner —
class O/S missing
2,894,735
 — — 31 Oct 2023
3/4/5
Jason David Hanson
3/4/5
Chief Executive Officer, Director —
class O/S missing
512,826
 — — 31 Oct 2023
3/4/5
Richard P. Bryce
3/4/5
Chief Medical Officer —
class O/S missing
153,000
 — — 30 Nov 2023
3/4/5
James C. Sullivan
3/4/5
Chief Scientific Officer —
class O/S missing
118,509
 — — 31 Oct 2023
3/4/5
BVF PARTNERS L P/IL
3/4/5
10%+ Owner —
class O/S missing
104,257
 — — 31 Oct 2023
3/4/5

Institutional Holders of enGene Therapeutics Inc. - Common Shares (ENGN) as of Q4 2023

As of 31 Dec 2023, enGene Therapeutics Inc. - Common Shares (ENGN) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,187,864 shares. The largest 10 holders included FCPM III SERVICES B.V., BVF INC/IL, Blue Owl Capital Holdings LP, Omega Fund Management, LLC, Vivo Capital, LLC, Polar Asset Management Partners Inc., ROYAL BANK OF CANADA, GOLDMAN SACHS GROUP INC, CITADEL ADVISORS LLC, and UBS Group AG. This page lists 11 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2023 vs Q4 2025 Across Filers

Q4 2025 holders
57
Q4 2023 holders
11
Holder diff
-46
Investor Q4 2025 Shares Q4 2023 Shares Share Diff Share Chg % Q4 2025 Value $ Q4 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .